Login to Your Account

Week in Washington

Monday, October 31, 2011

The biopharma industry is asking for a three-month grace period on implementation of the Physicians Payment Sunshine provision, since the Department of Health and Human Services has not yet developed guidance.

Par Pharmaceutical Inc. filed suit against the FDA for violating the Federal Food, Drug and Cosmetic Act and the First Amendment by restricting truthful speech about approved uses of drugs.


To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription